BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24415490)

  • 1. Kanamycin-furosemide ototoxicity in the mouse cochlea: a 3-dimensional analysis.
    Schmitz HM; Johnson SB; Santi PA
    Otolaryngol Head Neck Surg; 2014 Apr; 150(4):666-72. PubMed ID: 24415490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic lipopolysaccharide induces cochlear inflammation and exacerbates the synergistic ototoxicity of kanamycin and furosemide.
    Hirose K; Li SZ; Ohlemiller KK; Ransohoff RM
    J Assoc Res Otolaryngol; 2014 Aug; 15(4):555-70. PubMed ID: 24845404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of combination kanamycin-furosemide versus kanamycin alone in the mouse cochlea.
    Hirose K; Sato E
    Hear Res; 2011 Feb; 272(1-2):108-16. PubMed ID: 21044672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an ototoxicity model in the adult CBA/CaJ mouse and determination of a golden window of corticosteroid intervention for otoprotection.
    Fernandes VT; Lin VY
    J Otolaryngol Head Neck Surg; 2014 Apr; 43(1):12. PubMed ID: 24762042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ototoxic effects of the interaction between kanamycin and ethacrynic acid. Cochlear ultrastructure correlated with cochlear potentials and kanamycin levels.
    Russell NJ; Fox KE; Brummett RE
    Acta Otolaryngol; 1979; 88(5-6):369-81. PubMed ID: 532612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of the TGF-β signaling exacerbates degeneration of auditory neurons in kanamycin-induced ototoxicity in mice.
    Nitta Y; Kurioka T; Mogi S; Sano H; Yamashita T
    Sci Rep; 2024 May; 14(1):10910. PubMed ID: 38740884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sox2 and JAGGED1 expression in normal and drug-damaged adult mouse inner ear.
    Oesterle EC; Campbell S; Taylor RR; Forge A; Hume CR
    J Assoc Res Otolaryngol; 2008 Mar; 9(1):65-89. PubMed ID: 18157569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profound hearing loss in the cat following the single co-administration of kanamycin and ethacrynic acid.
    Xu SA; Shepherd RK; Chen Y; Clark GM
    Hear Res; 1993 Nov; 70(2):205-15. PubMed ID: 8294265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atoh1 induces auditory hair cell recovery in mice after ototoxic injury.
    Kraft S; Hsu C; Brough DE; Staecker H
    Laryngoscope; 2013 Apr; 123(4):992-9. PubMed ID: 23483451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scar formation in mice deafened with kanamycin and furosemide.
    Żak M; van der Linden CA; Bezdjian A; Hendriksen FG; Klis SF; Grolman W
    Microsc Res Tech; 2016 Aug; 79(8):766-72. PubMed ID: 27311812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effect of 3', 4'-dideoxykanamycin B and potent diuretics on the cochlea. (A scanning and transmission electron microscopic evaluation).
    Nakai Y
    Laryngoscope; 1977 Sep; 87(9 Pt 1):1548-58. PubMed ID: 895312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase-independent pathways of hair cell death induced by kanamycin in vivo.
    Jiang H; Sha SH; Forge A; Schacht J
    Cell Death Differ; 2006 Jan; 13(1):20-30. PubMed ID: 16021180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rapid cochlea lesion induced by co-administration of kanamycin and furosemide in mouse].
    Xiong H; Chu HQ; Huang XW; Cui YH; Zhou LQ; Chen J; Li JL; Wang Y; Chen QG; Li ZY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Mar; 45(3):222-8. PubMed ID: 20450703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Furosemide-induced alteration of drug pathway to cochlea.
    Yamane H; Nakai Y; Konishi K
    Acta Otolaryngol Suppl; 1988; 447():28-35. PubMed ID: 3055805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a model of cochlear lesions in rats to study potential gene therapy for sensorineural hearing loss.
    Wang Y; Qiao L; Chen Y; Wen L; Yue B; Qiu J; Wu S
    Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2147-54. PubMed ID: 26574172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kanamycin Damages Early Postnatal, but Not Adult Spiral Ganglion Neurons.
    Gao K; Ding D; Sun H; Roth J; Salvi R
    Neurotox Res; 2017 Nov; 32(4):603-613. PubMed ID: 28656549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative ototoxicity of bumetanide and furosemide when used in combination with kanamycin.
    Brummett RE; Bendrick T; Himes D
    J Clin Pharmacol; 1981; 21(11):628-36. PubMed ID: 7338574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ototoxicity of kanamycin sulfate and the barriers in the inner ear.
    Komune S; Snow JB
    Otolaryngol Head Neck Surg; 1981; 89(6):1013-8. PubMed ID: 6801580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural correlates of selective outer hair cell destruction following kanamycin intoxication in the chinchilla.
    Ryan AF; Woolf NK; Bone RC
    Hear Res; 1980 Dec; 3(4):335-51. PubMed ID: 7451380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of cochlear electrophysiology and morphology after combined administration of kanamycin and furosemide.
    Versnel H; Agterberg MJ; de Groot JC; Smoorenburg GF; Klis SF
    Hear Res; 2007 Sep; 231(1-2):1-12. PubMed ID: 17475424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.